Complement is a subsystem of immunity that's fast acting and disregulated in multiple inflammatory diseases. Inhibition of complement is a young niche that's gonna get lots more attention soon.
NEW HAVEN, Conn., & AMSTERDAM--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Complement Pharma today announced a partnership to co-develop the preclinical C6 complement inhibitor ...